{
    "SPADE_UN_23237": {
        "Sequence Information": {
            "Peptide Name": "IP-1",
            "Sequence": "KFLNRFWHWLQLKPGQPMY",
            "Sequence Length": 19,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Moonlighting peptides with emerging function.",
                    "Pubmed ID": "22808104",
                    "Reference": "PLoS One. 2012;7:e40125",
                    "Author": "Rodríguez Plaza JG, Villalón Rojas A, Herrera S, Garza-Ramos G, Torres Larios A, Amero C, Zarraga Granados G, Gutiérrez Aguilar M, Lara Ortiz MT, Polanco Gonzalez C, Uribe Carvajal S, Coria R, Peña Díaz A, Bredesen DE, Castro-Obregon S, del Rio G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22808104"
                },
                {
                    "Title": "Cell penetrating peptides and cationic antibacterial peptides: two sides of the same coin.",
                    "Pubmed ID": "24706763",
                    "Reference": "J Biol Chem. 2014;289:14448-14457",
                    "Author": "Rodríguez Plaza JG, Morales-Nava R, Diener C, Schreiber G, Gonzalez ZD, Lara Ortiz MT, Ortega Blake I, Pantoja O, Volkmer R, Klipp E, Herrmann A, del Rio G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24706763"
                },
                {
                    "Title": "Antimicrobial Peptide against Mycobacterium Tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis.",
                    "Pubmed ID": "33182483",
                    "Reference": "Pharmaceutics. 2020;12:1071",
                    "Author": "Peláez Coyotl EA, Barrios Palacios J, Muciño G, Moreno-Blas D, Costas M, Montiel Montes T, Diener C, Uribe-Carvajal S, Massieu L, Castro-Obregon S, Espinosa OR, Mata Espinosa D, Barrios-Payan J, León Contreras JC, Corzo G, Hernandez-Pando R, del Rio G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33182483"
                }
            ],
            "Mass": 2489.94,
            "PI": 10.29,
            "Net Charge": 4,
            "Hydrophobicity": -0.73,
            "Frequent Amino Acids": "LFK",
            "Absent Amino Acids": "ACDEIOSTUV",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 13,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_23237",
            "Similar Sequences": [],
            "Hemolytic Activity": "Human embryonic kidney HEK293T cells:25% Killing=50 µM,Mouse Embryonic Fibroblasts (MEF):68% Killing=50 µM,Murine macrophage cells J774A.1:25% Killing=64 µM",
            "Target Organism": "Escherichia coli DH10B(MIC=20µM),Saccharomyces cerevisiae BY4741(MIC=10µM),Mycobacterium tuberculosis H37Rv(IC50=99.27µM),Mycobacterium tuberculosis CIBIN99(IC50=92.66µM)"
        }
    }
}